JP5844894B2 - シート成形体および止血材 - Google Patents

シート成形体および止血材 Download PDF

Info

Publication number
JP5844894B2
JP5844894B2 JP2014515699A JP2014515699A JP5844894B2 JP 5844894 B2 JP5844894 B2 JP 5844894B2 JP 2014515699 A JP2014515699 A JP 2014515699A JP 2014515699 A JP2014515699 A JP 2014515699A JP 5844894 B2 JP5844894 B2 JP 5844894B2
Authority
JP
Japan
Prior art keywords
fibrinogen
thrombin
molded body
polymer
molded article
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014515699A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2013172472A1 (ja
Inventor
由佳子 景山
由佳子 景山
賢太郎 藤永
賢太郎 藤永
鮎子 山口
鮎子 山口
佑介 秋山
佑介 秋山
晃稔 大野
晃稔 大野
勧 本多
勧 本多
真 佐竹
真 佐竹
博章 兼子
博章 兼子
隆幸 今村
隆幸 今村
亮一 川村
亮一 川村
正樹 平嶋
正樹 平嶋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Teijin Pharma Ltd
Teijin Ltd
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Teijin Pharma Ltd
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken, Teijin Pharma Ltd, Teijin Ltd filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Priority to JP2014515699A priority Critical patent/JP5844894B2/ja
Publication of JPWO2013172472A1 publication Critical patent/JPWO2013172472A1/ja
Application granted granted Critical
Publication of JP5844894B2 publication Critical patent/JP5844894B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0036—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0052—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/009—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F2013/00361—Plasters
    • A61F2013/00365—Plasters use
    • A61F2013/00463—Plasters use haemostatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Laminated Bodies (AREA)
  • Medicinal Preparation (AREA)
  • Polymers & Plastics (AREA)
JP2014515699A 2012-05-14 2013-05-13 シート成形体および止血材 Active JP5844894B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014515699A JP5844894B2 (ja) 2012-05-14 2013-05-13 シート成形体および止血材

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
JP2012110391 2012-05-14
JP2012110392 2012-05-14
JP2012110394 2012-05-14
JP2012110393 2012-05-14
JP2012110391 2012-05-14
JP2012110394 2012-05-14
JP2012110393 2012-05-14
JP2012110392 2012-05-14
JP2013003273 2013-01-11
JP2013003273 2013-01-11
JP2014515699A JP5844894B2 (ja) 2012-05-14 2013-05-13 シート成形体および止血材
PCT/JP2013/063872 WO2013172472A1 (ja) 2012-05-14 2013-05-13 シート成形体および止血材

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015226374A Division JP6277172B2 (ja) 2012-05-14 2015-11-19 シート成形体および止血材

Publications (2)

Publication Number Publication Date
JPWO2013172472A1 JPWO2013172472A1 (ja) 2016-01-12
JP5844894B2 true JP5844894B2 (ja) 2016-01-20

Family

ID=49583870

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014515699A Active JP5844894B2 (ja) 2012-05-14 2013-05-13 シート成形体および止血材
JP2015226374A Active JP6277172B2 (ja) 2012-05-14 2015-11-19 シート成形体および止血材

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015226374A Active JP6277172B2 (ja) 2012-05-14 2015-11-19 シート成形体および止血材

Country Status (23)

Country Link
US (2) US10485894B2 (cg-RX-API-DMAC10.html)
EP (1) EP2851095B1 (cg-RX-API-DMAC10.html)
JP (2) JP5844894B2 (cg-RX-API-DMAC10.html)
KR (1) KR102259117B1 (cg-RX-API-DMAC10.html)
CN (1) CN104271164B (cg-RX-API-DMAC10.html)
AR (1) AR091031A1 (cg-RX-API-DMAC10.html)
AU (1) AU2013261312B2 (cg-RX-API-DMAC10.html)
BR (1) BR112014028471B8 (cg-RX-API-DMAC10.html)
CA (1) CA2873162C (cg-RX-API-DMAC10.html)
DK (1) DK2851095T3 (cg-RX-API-DMAC10.html)
ES (1) ES2890098T3 (cg-RX-API-DMAC10.html)
HU (1) HUE056396T2 (cg-RX-API-DMAC10.html)
IL (1) IL235689B (cg-RX-API-DMAC10.html)
MX (1) MX357254B (cg-RX-API-DMAC10.html)
MY (1) MY173719A (cg-RX-API-DMAC10.html)
NZ (1) NZ631084A (cg-RX-API-DMAC10.html)
PH (1) PH12014502535A1 (cg-RX-API-DMAC10.html)
PL (1) PL2851095T3 (cg-RX-API-DMAC10.html)
RU (1) RU2669569C2 (cg-RX-API-DMAC10.html)
SG (1) SG11201407549YA (cg-RX-API-DMAC10.html)
TW (1) TWI584825B (cg-RX-API-DMAC10.html)
WO (1) WO2013172472A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA201408258B (cg-RX-API-DMAC10.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091031A1 (es) * 2012-05-14 2014-12-30 Teijin Ltd Producto en planchas y material hemostatico
MX384582B (es) * 2015-11-06 2025-03-14 Ethicon Inc Agregados celulósicos hemostáticos compactados.
EP3427726B1 (en) * 2016-03-07 2023-05-03 Osaka University Sustained drug release sheet for treating nerve injury
CN106267328B (zh) * 2016-09-20 2019-04-12 安徽思维特生物科技有限公司 一种聚己内酯-胎牛皮胶原纤维复合止血凝胶的制备方法
BR112019014236A2 (pt) * 2017-01-23 2020-03-17 Afyx Therapeutics A/S Método para a fabricação de um produto de duas camadas à base de fibras eletrofiadas
KR102029926B1 (ko) * 2017-12-14 2019-10-08 금오공과대학교 산학협력단 풀루란을 이용한 하이드로젤 지혈제 및 그 제조방법
CA3090405A1 (en) * 2018-02-15 2019-08-22 Biom'up France SAS Multi-dimensional hemostatic product and method for producing the same
MX2021011420A (es) 2019-03-20 2021-10-13 Astellas Pharma Inc Lamina hemostatica portadora de trombina.
JP7555981B2 (ja) 2019-07-12 2024-09-25 ガット テクノロジーズ ビー．ブイ． 組織接着性シートを調製するための方法
WO2021009013A1 (en) 2019-07-12 2021-01-21 Gatt Technologies B.V. Biocompatible, flexible, haemostatic sheet
JP7530182B2 (ja) * 2020-02-06 2024-08-07 株式会社東芝 生体適合部材
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent
EP4456935A1 (en) 2021-12-30 2024-11-06 Baxter International Inc. Fibrinogen and thrombin solutions for a fibrin sealant and fibrin sealant kit
CN117771417A (zh) * 2022-09-29 2024-03-29 苏州泽璟生物制药股份有限公司 一种含重组人凝血酶的生物可降解止血粉及其制备方法和用途
WO2025144087A1 (ru) * 2023-12-24 2025-07-03 Олег ЕВСЕЕНКОВ Гемостатическое средство
CN118236562A (zh) * 2024-03-21 2024-06-25 额尔德木图 一种凝血酶涂层医用弹簧圈的制备方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3105624A1 (de) 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
SE439078B (sv) 1984-07-17 1985-05-28 Philips Norden Ab Anordning vid en avstembar magnetron
DE19521324C1 (de) 1995-06-12 1996-10-31 Immuno Ag Gewebeklebstoff und Verwendung desselben als Hämostyptikum
US5702715A (en) * 1995-10-27 1997-12-30 Drying Technology Reinforced biological sealants
EP0835667B1 (en) 1996-03-15 2005-11-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Spray device for applying tissue adhesive
ATE439150T1 (de) 1997-11-17 2009-08-15 Haemacure Corp Ein hyaluronsäurederivat enthaltende fibrinsiegel-oder fibrinklebmasse
US6762336B1 (en) 1998-01-19 2004-07-13 The American National Red Cross Hemostatic sandwich bandage
US6056970A (en) * 1998-05-07 2000-05-02 Genzyme Corporation Compositions comprising hemostatic compounds and bioabsorbable polymers
JP4480270B2 (ja) 1998-05-19 2010-06-16 ジ・アメリカン・ナショナル・レッド・クロス 止血サンドウィッチ包帯
PL206194B1 (pl) * 2001-01-25 2010-07-30 Nycomed Pharma Asnycomed Pharma As Sposób wytwarzania zawiesiny cząstek fibrynogenu i trombiny, zawiesina zawierająca fibrynogen, trombinę i alkohol oraz sposób powlekania nośnika taką zawiesiną
US7135189B2 (en) 2001-08-23 2006-11-14 Boston Scientific Scimed, Inc. Compositions and techniques for localized therapy
US20030198659A1 (en) * 2001-10-25 2003-10-23 Hoffmann Michael P. Fibrous pest control
US20040101546A1 (en) * 2002-11-26 2004-05-27 Gorman Anne Jessica Hemostatic wound dressing containing aldehyde-modified polysaccharide and hemostatic agents
WO2004032713A2 (en) * 2002-10-04 2004-04-22 Nanomatrix, Inc. Sealants for skin and other tissues
WO2004043503A1 (ja) * 2002-11-14 2004-05-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute トロンビン固定化生体吸収性合成不織布
US20060051340A1 (en) 2003-01-20 2006-03-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Hemostatic materials
DE602004026561D1 (de) 2003-02-13 2010-05-27 Teijin Ltd Poröse faser, poröses fasergebilde und herstellungsverfahren
US20070172651A1 (en) 2004-03-16 2007-07-26 Takanori Miyoshi Ultrafine polyactic acid fibers and fiber structure, and process for their production
JP4526851B2 (ja) 2004-03-31 2010-08-18 明彦 谷岡 多糖類のナノスケールの繊維および成形体
KR20070026578A (ko) 2004-05-21 2007-03-08 자이단호진 가가쿠오요비겟세이료호겐쿠쇼 조직 봉합제
JP4481994B2 (ja) * 2004-09-07 2010-06-16 帝人株式会社 生体吸収性多孔体
ES2530989T3 (es) 2004-10-20 2015-03-09 Ethicon Inc Hemostático absorbible
US20090136651A1 (en) * 2006-03-28 2009-05-28 Gustavo Larsen Method of Manufacturing Fibrous Hemostatic Bandages
CA2649081A1 (en) 2006-04-10 2007-10-18 Ethicon, Inc. A reinforced absorbable multilayered hemostatic wound dressing and method of making
US20100254961A1 (en) 2007-09-05 2010-10-07 Taiyokagaku Co., Ltd. Water-soluble electrospun sheet
WO2009073854A1 (en) * 2007-12-06 2009-06-11 Nanosys, Inc. Resorbable nanoenhanced hemostatic structures and bandage materials
JP5192254B2 (ja) * 2008-02-08 2013-05-08 一般財団法人化学及血清療法研究所 シート状組織接着剤
WO2009128474A1 (ja) 2008-04-16 2009-10-22 財団法人化学及血清療法研究所 トロンビン固定化生体吸収性シート製剤の製造方法
JP2010069031A (ja) * 2008-09-19 2010-04-02 Chemo Sero Therapeut Res Inst シート状フィブリン糊接着剤
WO2010143711A1 (ja) 2009-06-11 2010-12-16 一般財団法人化学及血清療法研究所 創傷被覆材
EP2477617B1 (en) * 2009-09-18 2018-01-31 Bioinspire Technologies Inc. Free-standing biodegradable patch
US8349354B2 (en) * 2009-09-22 2013-01-08 Ethicon, Inc. Composite layered hemostasis device
US8273369B2 (en) * 2010-05-17 2012-09-25 Ethicon, Inc. Reinforced absorbable synthetic matrix for hemostatic applications
US8329211B2 (en) 2010-05-17 2012-12-11 Ethicon, Inc. Reinforced absorbable multi-layered fabric for hemostatic applications
JP5889188B2 (ja) * 2010-07-20 2016-03-22 一般財団法人化学及血清療法研究所 組織接着用シート製剤
US9861590B2 (en) 2010-10-19 2018-01-09 Covidien Lp Self-supporting films for delivery of therapeutic agents
JP5905590B2 (ja) 2011-10-26 2016-04-20 エルジー エレクトロニクス インコーポレイティド 無線通信システムにおける制御チャネルを割り当てる方法及び装置
KR102037555B1 (ko) * 2012-05-14 2019-10-28 데이진 가부시키가이샤 멸균 조성물
AR091031A1 (es) * 2012-05-14 2014-12-30 Teijin Ltd Producto en planchas y material hemostatico

Also Published As

Publication number Publication date
JP2016073641A (ja) 2016-05-12
KR20150020536A (ko) 2015-02-26
PH12014502535B1 (en) 2015-01-21
AR091031A1 (es) 2014-12-30
CA2873162C (en) 2021-07-27
BR112014028471B1 (pt) 2020-05-05
EP2851095A1 (en) 2015-03-25
HUE056396T2 (hu) 2022-02-28
JPWO2013172472A1 (ja) 2016-01-12
CA2873162A1 (en) 2013-11-21
PH12014502535A1 (en) 2015-01-21
TW201406410A (zh) 2014-02-16
ZA201408258B (en) 2015-10-28
US20150151020A1 (en) 2015-06-04
RU2669569C2 (ru) 2018-10-12
IL235689A0 (en) 2015-01-29
DK2851095T3 (da) 2021-09-13
AU2013261312B2 (en) 2016-11-17
WO2013172472A1 (ja) 2013-11-21
BR112014028471B8 (pt) 2020-05-26
HK1204774A1 (en) 2015-12-04
AU2013261312A1 (en) 2015-03-05
US11433160B2 (en) 2022-09-06
MX2014013817A (es) 2015-05-11
ES2890098T3 (es) 2022-01-17
US20200046877A1 (en) 2020-02-13
EP2851095A4 (en) 2015-06-17
EP2851095B1 (en) 2021-07-14
NZ631084A (en) 2016-06-24
KR102259117B1 (ko) 2021-05-31
US10485894B2 (en) 2019-11-26
JP6277172B2 (ja) 2018-02-07
MY173719A (en) 2020-02-18
BR112014028471A2 (pt) 2018-07-17
RU2014150544A (ru) 2016-07-10
SG11201407549YA (en) 2014-12-30
CN104271164B (zh) 2017-11-17
PL2851095T3 (pl) 2022-01-10
IL235689B (en) 2021-10-31
TWI584825B (zh) 2017-06-01
CN104271164A (zh) 2015-01-07
MX357254B (es) 2018-07-03

Similar Documents

Publication Publication Date Title
JP6277172B2 (ja) シート成形体および止血材
CN108348633B (zh) 压实止血纤维素聚集体
CN106457750B (zh) 多层片材和使用其得到的一体化片材以及其制造方法
KR20070092701A (ko) 지혈용 강화 흡수성 다층 상처 드레싱 및 제조방법
CN105188740A (zh) 包含凝血酶和纤维蛋白原的粉末制剂
JP5746430B2 (ja) 滅菌組成物
KR101733865B1 (ko) 전기방사형 고분자 섬유를 포함하는 지혈재 및 그 제조방법
Mukherjee et al. Unlocking the potential of engineered biopolymer-based nanofibers for the management of diabetic wounds: a review
JP5927061B2 (ja) シート状止血材
JP5889188B2 (ja) 組織接着用シート製剤
HK1204774B (en) Sheet molding and hemostatic material
JP5856785B2 (ja) 止血効果に優れたシート状止血材
JP5479584B2 (ja) 生体糊用補強材及びその製造方法
JPWO2012029971A1 (ja) フィブリン糊と繊維成形体との複合体
JP5519793B2 (ja) 低帯電性繊維およびその製造方法
HK1102546A1 (en) Hemostatic agent for topical and internal use
HK1102546B (en) Hemostatic agent for topical and internal use

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151021

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151119

R150 Certificate of patent or registration of utility model

Ref document number: 5844894

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250